Search - tctmd.com

Displaying 1 - 20 of 79

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

Presentation THT 2025

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Presenter: Jacob Abraham

February 12, 2025

Presentation THT 2025

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Presenter: Miguel Woodham

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Presenter: Katherine Wood

February 12, 2025

Presentation THT Abstracts 2025

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Presenter: Miguel Woodham

February 11, 2025

Presentation THT Abstracts 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT Abstracts 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

February 11, 2025

Presentation THT Abstracts 2025

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Presenter: Tahira Qadeer

February 11, 2025

Presentation THT Abstracts 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Presenter: Tahira Qadeer

February 11, 2025

Presentation THT 2025

Impella 5.5: A GameChanger for Cardiogenic Shock

Presenter: Jerome Crowley

February 11, 2025

Presentation THT 2025

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Presenter: Manreet Kanwar

February 11, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

Advertisement

TCTMD’s Top 10 Most Popular Stories for September 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Impella 5.5: A GameChanger for Cardiogenic Shock

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

January 2025 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content